Adenovirus-mediated cytotoxic gene therapy for prostate cancer offers a new therapeutic modality. Currently, intraprostatic injection is used to target vectors to the prostate. Transcriptional targeting of genes under the control of prostate-speci®c promoters had been shown to be speci®c, but is limited by a low expression. Increasing the transduction of the vector (Adv) into the cell might increase the expression of therapeutic genes. The adenovirus uses the Coxsackie adenoviral receptor (CAR) to adhere to the cell membrane by means of its viral knob, after which internalisation occurs under the in¯uence of integrins. Many tumour cells have limited or absent CAR. We have evaluated the possibility of retargeting adenoviral vectors towards the pantumoral EpCAM antigen and the ®broblast growth factor receptor (FGFR) in order to increase transduction in vitro.
Method
The presence of CAR, EpCAM and various integrins was assessed by¯ow cytometric analysis (FACS). Conjugates between monoclonal anti-knob and FGF or monoclonal alpha-323 (antibody against EpCAM) were incubated with Adv-CMV-LacZ to retarget the vector. After infection with various prostate cancer cell lines (DU 145, PC 3 and PC 346C) the expression of beta-galactosidase was determined by staining and activity assays.
Results
CAR was expressed highly on the relatively well-differentiated prostate-speci®c antigen (PSA)-producing cell line PC 346C derived from a primary prostate cancer, but far less (DU 145) or not (PC 3) on cell lines derived from metastases. Expression of EpCAM was observed on all cell lines. Infection with Adv-CMV-LacZ (MOI 100) occurred in 100% of PC 346C cells, but minimally (0.2± 2%) in DU 145 and PC 3 cell lines. Vectors retargeted to EpCAM or FGFR showed a receptor-speci®c transduction and a highly increased expression of LacZ, especially in DU 145 en PC3.
Conclusion
The natural tropism of adenoviral vectors can be changed by retargeting conjugates to speci®c surface membrane receptors on prostate cancer cells. Due to this retargeting, the transduction ef®cacy is increased, especially in cell lines that cannot normally easily be infected. Retargeting may induce gene expression, which might become important for the therapeutic treatment of polyclonal prostate cancers.
